NEOCARZINOSTATIN VERSUS M-AMSA OR DOXORUBICIN IN HEPATOCELLULAR-CARCINOMA

被引：27

作者：

FALKSON, G

MACINTYRE, JM

SCHUTT, AJ

COETZER, B

JOHNSON, LA

SIMSON, IW

DOUGLASS, HO

机构：

[1] UNIV PRETORIA,PRETORIA,SOUTH AFRICA

[2] DANA FARBER CANC INST,BOSTON,MA

[3] MAYO CLIN & MAYO FDN,ROCHESTER,MN 55901

[4] BROWN UNIV,PROVIDENCE,RI 02912

[5] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,BUFFALO,NY 14263

来源：

JOURNAL OF CLINICAL ONCOLOGY | 1984年 / 2卷 / 06期

关键词：

D O I：

10.1200/JCO.1984.2.6.581

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：581 / 584

页数：4

共 11 条

[1] PHASE-II TRIAL OF (META-AMSA) 4'-9-(ACRIDINYLAMINO)-METHANESULFON-META-ANISIDE IN PRIMARY LIVER-CANCER [J].

CHENG, E ;

LIGHTDALE, C ;

YOUNG, C ;

YAGODA, A ;

FORTNER, J ;

GOLBEY, R .

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1983, 6 (02) :211-213

[2]

COX DR, 1972, J ROYAL STAT SOC L B, V26, P103

[3]

FALKSON G, 1978, CANCER, V42, P2149, DOI 10.1002/1097-0142(197811)42:5<2149::AID-CNCR2820420510>3.0.CO

[4]

2-5

[5] A PHASE-II STUDY OF NEOCARZINOSTATIN (NSC 157365) IN MALIGNANT HEPATOMA - AN EASTERN COOPERATIVE ONCOLOGY GROUP PILOT-STUDY [J].

FALKSON, G ;

VONHOFF, D ;

KLAASSEN, D ;

DUPLESSIS, H ;

VANDERMERWE, CF ;

VANDERMERWE, AM ;

CARBONE, PP .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1980, 4 (01) :33-36

[6]

FALKSON G, 1981, CANCER CHEMOTH PHARM, V6, P127

[7]

FALKSON G, CANCER

[8]

FREEMAN GH, 1951, BIOMETRIKA, V38, P141, DOI 10.1093/biomet/38.1-2.141

[9] NONPARAMETRIC-ESTIMATION FROM INCOMPLETE OBSERVATIONS [J].

KAPLAN, EL ;

MEIER, P .

JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1958, 53 (282) :457-481

[10] TOXICITY AND RESPONSE CRITERIA OF THE EASTERN-COOPERATIVE-ONCOLOGY-GROUP [J].

OKEN, MM ;

CREECH, RH ;

TORMEY, DC ;

HORTON, J ;

DAVIS, TE ;

MCFADDEN, ET ;

CARBONE, PP .

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1982, 5 (06) :649-655

← 1 2 →